Brigham Buhler’s face has been appearing everywhere in MAGA media lately—on Joe Rogan’s podcast, Tucker Carlson’s show, and even on InfoWars with Alex Jones—where he is always hailed as a brave whistleblower exposing Big Pharma. He aligned himself with figures like Robert F. Kennedy Jr. and Sen. Ron Johnson, presenting himself as an “advisor” in the health freedom movement. At first glance, Buhler seems to speak our language: He condemns the FDA as corrupt, attacks Big Pharma’s greed, and promotes “health freedom” alongside alternative cures. But patriots, take caution—beneath the righteous rhetoric, Buhler is the head of a rogue medical operation, and he has been accused of illegally producing medications and enriching himself, which now has many saying he is putting patient safety at risk across the nation.
Guys Like Buhler Embarrass and Undermine the MAHA Movement
Buhler is the founder of a Houston-based drug compounding business, Revive RX Pharmacy, and a telehealth clinic called Ways2Well, which he launched in 2018 as part of his “wellness” venture. He frequently touts himself as a former pharmaceutical rep who saw the light and is now battling the “medical establishment.”
On the June 27, 2023, episode of The Joe Rogan Experience, Buhler claimed the FDA is rife with conflicts of interest, asserting, “A majority of the FDA’s funding comes from private industry… and they are being influenced by these companies.” He and Rogan suggested the FDA conspires with Big Pharma to target small pharmacies, with Rogan adding, “Putting something on the dangerous list with no evidence seems like straight-cut corruption.” Buhler further argued that peptides and other alternative therapies are being suppressed so Big Pharma can patent them, claiming, “All clues lead to FDA helping Big Pharma to patent certain peptides and compounds by classifying them as dangerous.” In other words, Buhler positions himself as the underdog pharmacist hero, standing against a corrupt, industry-controlled FDA.
Buhler’s Rallying Cry Against Healthcare Corruption Resonates Strongly Within MAGA Circles
He’s been invited onto the Tucker Carlson show, participated in a roundtable with RFK Jr. discussing America’s healthcare system, and even appeared as a “medical industry expert” on programs featuring figures like Alex Jones and Dr. Jordan Peterson.
Just a few weeks ago, Buhler posted a video about meeting with RFK Jr. in Washington, D.C., prior to the nomination of unlicensed medical doctor Casey Means for U.S. Surgeon General. This nomination came despite concerns over Means’ affinity for what some are calling witchcraft, he use of illegal psilocybin, and her father’s efforts to promote transgenderism to children, among many other other issues uncovered by independent investigative journalist Laura Loomer.
Given Buhler’s activities, it’s no wonder why many in MAHA are calling him out for attempting to align himself with the legitimacy of MAGA movement icons to boost his own credibility, and ultimately, enrich himself.
What Buhler Doesn’t Disclose to the MAGA Faithful
Here’s what Buhler doesn’t disclose to the MAGA faithful: His pharmacy, Revive RX, has been repeatedly documented as violating the law and putting patients at risk, attracting serious scrutiny from the very regulators he vilifies. While Buhler was touring, calling the FDA corrupt, FDA investigators were uncovering egregious safety failures at his Revive RX facility.
In a June 30, 2023, letter, the FDA outlined how an inspection of Revive RX revealed “unsanitary conditions” in the pharmacy’s sterile drug production area. According to the FDA letter, Buhler’s employees were preparing supposedly sterile injectables in ways that could easily contaminate the drugs. Inspectors observed one employee reaching bare-handed over open vials of medicine while capping them, and another failing to sanitize their gloves after handling trash in the cleanroom.
The pharmacy was even using a non-pharmaceutical-grade filter to sterilize drug solutions, without testing whether the filter actually worked. Basic safety measures, like smoke tests to ensure proper airflow in cleanrooms, were never conducted. The FDA explicitly warned that Revive RX’s supposedly sterile products were adulterated under federal law—in simple terms, they were tainted by contamination risk.
Unsurprisingly, Buhler failed to mention his facility’s sanitation failures or his sale of illegal biological drugs during his testimony before the U.S. Senate, where he claimed the healthcare system is rigged.
The Illegality of Buhler’s Operations
Even more alarming, the FDA discovered that Buhler’s pharmacy was making and selling unapproved biological drugs that the agency outlawed compounders from producing on March 23, 2020. For instance, Revive RX was illegally manufacturing human chorionic gonadotropin (HCG)—a hormone drug the FDA explicitly told Buhler is an “unapproved new drug” and a biological product requiring licensed approval, which the company does not have. “You do not have any FDA-approved applications on file for human chorionic gonadotropin (HCG) that you manufacture,” the FDA wrote, categorically declaring the product unlawful.
In other words, Buhler’s pharmacy could possibly still be illicitly compounding and selling HCG—flouting federal law while positioning himself as a righteous outsider. While Buhler condemns the FDA and Big Pharma as the root cause of America’s declining health, he is operating a business that could put patients’ health at risk nationwide by selling illegal medications.
But There’s More
Buhler’s company was also compounding other biological products, such as Thymosin Beta-4 (TB4), for injury repair—products that regulators never approved for use. Only after being caught did Buhler’s team claim they “voluntarily discontinued” making TB4. The FDA’s letter emphasized that Buhler’s pharmacy was selling illegal medications and manufacturing substances that, by law, require FDA approval and rigorous clinical trials. By selling these drugs to the public without approval, Revive RX was disregarding federal law and putting consumers at risk with compounds of questionable safety. In FDA terms, this constitutes misbranding and the sale of an unapproved new drug—violations that jeopardize public health and safety.
In short, Buhler’s operation bypasses the rules that legitimate drug manufacturers and pharmacies are bound to follow. Buhler is exhibiting the same greed and negligence for patient health that he accuses others of in his crusade against Big Pharma and the FDA.
A Major Incident That Put Patients at Risk
Buhler’s apologists might argue, “So what? The FDA is just nitpicking to protect Big Pharma’s interests.” But the dangers are very real—and they came to a head in a major incident last year that directly put patients at risk. In April 2024, Revive RX had to initiate a nationwide Class I recall of one of its drugs because the company mislabeled an injectable medication, with potentially devastating consequences. Revive RX had been selling vials of what customers believed was Tirzepatide—a high-demand weight-loss and diabetes drug (the active ingredient in Eli Lilly’s Mounjaro and ZepBound).
It turned out those vials actually contained testosterone cypionate instead of Tirzepatide.
Yep, that’s right. Buhler’s pharmacy mixed up the labels on a hormone steroid and a diabetes medication—a mistake that is as dangerous as it is absurd. The FDA classified this as a Class I recall, the most severe category, reserved for situations where “there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.”
The Consequences of Buhler’s Actions
Think about that: a diabetes patient expecting a lifesaving medication could have unknowingly injected testosterone instead, or someone seeking weight loss could have been dosed with a powerful hormone their body didn’t need.
Former FDA Commissioner Stephen Ostroff was appalled, stating, “It’s a serious error to mislabel a pharmaceutical in this way, and it suggests that they have lax processes and procedures in place.” Indeed, it was. At the time, Revive RX’s general counsel Matthew Ludwig, Esq.—who is currently being sued by the company’s competitor for alleged theft of trade secrets—alerted the FDA to the mix-up.
The recall affected 751 vials shipped across the country. This wasn’t a small error in a backroom; it was a mass distribution of dangerously mislabeled drugs. To make matters worse, the same pharmacy had also recalled batches of Tirzepatide in May 2023 for being “sub-potent” (too weak)—further evidence of the severe lack of quality control at Buhler’s company.
Where Are the Pharmacists?
Out of all these production disasters at Revive RX, one must ask: where are the pharmacists? Are there any trained professionals on site?
Enter Aaron Schneider, Buhler’s trusted right-hand man, and the pharmacist in charge. Schneider is supposed to ensure Revive follows all state and federal regulatory laws, procedures, and directives, but instead, patient safety takes a back seat to profit.
Need more proof of this profit-first, patient-safety-second model being implemented by Buhler and Schneider?
Revive RX had to issue a Class 1 recall for its illegally compounded biological drug, HCG, due to “Non-sterility; bacterial contamination identified as Paenibacillus Lautus.” Yes, another Class 1 recall. Did this stop Buhler and Schneider? Of course not. In fact, they doubled down and continued to illegally produce and sell more HCG to unsuspecting patients.
Buhler’s Response: Defiance, Not Remorse
Buhler’s response to these offenses hasn’t been to humble himself or address the issues, but to double down on defiance. Internally, Revive RX’s lawyer issued sterile corporate statements about “vetting quality systems” and “enhancing our organization.” But publicly, Buhler continues to deny the FDA’s authority over him. He portrays the FDA enforcement as a political hit job—depicting big government as coming after a small freedom fighter.
On Rogan’s show, even as news of the FDA’s actions against Revive RX was breaking, Buhler dismissed the agency’s authority, implying that FDA oversight didn’t apply to him because his pharmacy operates under a special exemption (Section 503A for compounders). He suggested that any claims his products were “unsafe” were fabricated to protect pharma monopolies. Buhler has shown no remorse for the serious safety violations at Revive RX; instead, he casts the FDA as an illegitimate, biased actor.
In his media appearances, he scoffed, saying, “peptides aren’t even a drug—they’re short amino acids,” and suggested the FDA has “no evidence” to justify banning compounds like BPC-157 or TB4. Buhler says he’s done nothing wrong—and he said it’s the “corrupt” FDA and Big Pharma, not him, that *actually* endanger patients. This is classic grifter behavior: when caught red-handed, Buhler plays the martyr and cries “persecution.”
Deny, Deflect, and Counter-Accuse—Buhler Style
Despite his deflection, pharmaceutical companies have taken notice of Buhler’s scheme—and they’re not buying his freedom-fighter act. In late 2023, Eli Lilly & Co. sued Revive RX for illegally compounding and selling knock-off versions of Lilly’s drug Tirzepatide (branded as Mounjaro/ZepBound). Lilly argued that Buhler was profiting off their patented medication without approval, under the guise of “compounding.”
If Big Pharma is so bad, why is Buhler copying their drugs?
Logical questions aside, something many in MAHA have a hard time with, Revive RX fought the case by twisting legal technicalities, effectively arguing that Lilly had no right to sue because only the FDA can enforce drug laws. (Imagine the irony: Buhler claims the FDA is corrupt, yet hides behind FDA authority in court to avoid liability.) The lawsuit highlighted how Buhler’s business model was to piggyback on big manufacturers’ innovations, siphoning off profit by selling copycat drugs outside the law. While a judge temporarily stayed Lilly’s case due to jurisdictional issues, the message was clear—Revive RX’s activities are seen as potentially unlawful and dangerous by mainstream medicine.
Unmasking the Deception: Buhler’s Exploitation of Health Freedom
It’s painfully clear that Brigham Buhler has been exploiting our side’s distrust of federal health agencies for his own gain and profit. He sprinkles just enough truth in his narrative – yes, the FDA and Big Pharma do have a revolving door; yes, we’ve seen regulatory capture and suppression of certain treatments—to earn our sympathy. But, then he uses that goodwill to peddle his own illegal, lab-made biological drugs, all while framing it as part of the revolution against Big Pharma.
Buhler has been playing a double game: to the public he’s the noble crusader on InfoWars and at MAGA events, but behind closed doors he’s selling illegal compounded biological drugs and running an operation so sloppy that vials of hormones were literally mailed out under the wrong labels. If we in the MAGA and health freedom movements embrace characters like Buhler, we’re handing our enemies the rope to hang us.
MAHA Should Be Concerned
The left-wing media would relish nothing more than to tie this man’s dangerous actions to the entire conservative health freedom cause. Imagine how quickly they’ll pounce if a diabetic patient dies or is harmed because they received a faulty drug from a pharmacy run by a self-proclaimed MAGA supporter who is securing meetings with RFK Jr. It would discredit everything legitimate we stand for in exposing Big Pharma corruption.
The facts are indisputable and well-sourced: Buhler’s Revive RX has shipped mislabeled drugs under a Class I recall, operated in filthy conditions according to FDA inspectors, and sells illegal compounded biological drugs that the FDA explicitly deems unlawful. These are the actions of a profiteering charlatan, not a patriot. No amount of smooth talking on podcasts can erase that reality.
We in the MAGA movement must have the courage to police our own ranks and call out grifters who endanger people while they wrap themselves in our flag and try to blend in like chameleons. Brigham Buhler is counting on us being so blinded by our distrust of the FDA that we overlook his recklessness and deceit. We can’t let that happen. Health freedom should mean empowering patients with safe alternatives—not empowering crooks to sell illegal compounded biological drugs under the false banner of liberty and wellness.
Standing for True Health Freedom: Exposing Grifters in Our Midst
Patriots, do your homework on those who claim to fight for you. Don’t forget, even President Trump himself went after Big Pharma’s misdeeds, but he would never condone distributing illegal compounded biological drugs to unsuspecting Americans. There is a world of difference between cutting red tape for innovation and ignoring basic drug safety and the rule of law. Brigham Buhler has crossed that line. If our movement embraces men like him, we not only risk the health of our fellow Americans, but we also risk the soul and credibility of our movement.
The next time you see Buhler or someone like him boasting about taking on the FDA, remember what’s lurking beneath the self righteous rhetoric. This is a grifter in patriot’s clothing, and it’s our duty to expose the truth—and to the American people we serve—to expose and reject such charlatans before they do more harm. Let’s stand for real health freedom, not Buhler’s brand of freedom-to-grift.
President Trump calls on us to speak out when we identify problems within the America First movement, and Brigham Buhler is certainly one of those problems.
The post MAHA Should Be Concerned About Grifters in Their Midst appeared first on Loomered.